<P> The updated version was modified to include dyslipidemia, age range, hypertension treatment, smoking, and total cholesterol, and it excluded diabetes, because Type 2 diabetes meanwhile was considered to be a CHD Risk Equivalent, having the same 10 - year risk as individuals with prior CHD . Patients with Type 1 diabetes were considered separately with slightly less aggressive goals; while at increased risk, no study had shown them to be at equivalent risk for CHD as those with previously diagnosed coronary disease or Type 2 diabetes . </P> <P> Some patients without known CHD have risk of cardiovascular events that is comparable to that of patients with established CHD . Cardiology professionals refer to such patients as having a CHD risk equivalent . These patients should be managed as patients with known CHD . </P> <P> CHD risk equivalents are patients with a 10 - year risk for MI or coronary death> 20% . CHD risk equivalents are primarily other clinical forms of atherosclerotic disease . The National Cholesterol Education Program NCEP's ATP III guidelines also list diabetes as a CHD risk equivalent since it also has a 10 - year risk for CHD around 20% . NCEP ATP III CHD risk equivalents are: </P> <Ol> <Li> clinical coronary heart disease (CHD) </Li> <Li> symptomatic carotid artery disease (CAD) </Li> <Li> peripheral arterial disease (PAD) </Li> <Li> abdominal aortic aneurysm (AAA) </Li> <Li> diabetes mellitus </Li> <Li> Chronic Kidney Disease </Li> </Ol>

Framingham 10 year risk of general cardiovascular disease